Since these results illuminate biological properties of CNB-001, the present study was aimed at investigating whether CNB-001 offers neuroprotection, by evaluating its effect on oxidative stress, behavioral impairments, expressions of TH, DAT, and VMAT2, and mitochondria ultrastructural analysis in a subacute MPTP model of PD. Here, SLC6A3 is linked to Parkinson disease.